Devyser Diagnostics AB
STO:DVYSR

Watchlist Manager

Devyser Diagnostics AB

STO:DVYSR

Watchlist

Dividends

Price: 133 SEK -3.62% Market Closed

Market Cap: 2.2B SEK

Have any thoughts about
Devyser Diagnostics AB?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 133 SEK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

DVYSR Alert

Devyser Diagnostics AB

133

-5 (-3.62%)

52 Week Range	63.6 139
Price Target

We'll email you a reminder when the closing price reaches SEK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Devyser Diagnostics AB

What unique competitive advantages
does Devyser Diagnostics AB hold over its rivals?

What risks and challenges
does Devyser Diagnostics AB face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Devyser Diagnostics AB.

What unique competitive advantages
does Devyser Diagnostics AB hold over its rivals?

What risks and challenges
does Devyser Diagnostics AB face in the near future?

Has there been any significant insider trading activity
in Devyser Diagnostics AB recently?

Summarize the latest earnings call
of Devyser Diagnostics AB.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Devyser Diagnostics AB.

Provide P/S
for Devyser Diagnostics AB.

Provide P/E
for Devyser Diagnostics AB.

Provide P/OCF
for Devyser Diagnostics AB.

Provide P/FCFE
for Devyser Diagnostics AB.

Provide P/B
for Devyser Diagnostics AB.

Provide EV/S
for Devyser Diagnostics AB.

Provide EV/GP
for Devyser Diagnostics AB.

Provide EV/EBITDA
for Devyser Diagnostics AB.

Provide EV/EBIT
for Devyser Diagnostics AB.

Provide EV/OCF
for Devyser Diagnostics AB.

Provide EV/FCFF
for Devyser Diagnostics AB.

Provide EV/IC
for Devyser Diagnostics AB.

Show me price targets
for Devyser Diagnostics AB made by professional analysts.

What are the Revenue projections
for Devyser Diagnostics AB?

How accurate were the past Revenue estimates
for Devyser Diagnostics AB?

What are the Net Income projections
for Devyser Diagnostics AB?

How accurate were the past Net Income estimates
for Devyser Diagnostics AB?

What are the EPS projections
for Devyser Diagnostics AB?

How accurate were the past EPS estimates
for Devyser Diagnostics AB?

What are the EBIT projections
for Devyser Diagnostics AB?

How accurate were the past EBIT estimates
for Devyser Diagnostics AB?

Compare the revenue forecasts
for Devyser Diagnostics AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Devyser Diagnostics AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Devyser Diagnostics AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of Devyser Diagnostics AB compared to its peers.

Compare the P/E ratios
of Devyser Diagnostics AB against its peers.

Discuss the investment returns and shareholder value creation
comparing Devyser Diagnostics AB with its peers.

Analyze the financial leverage
of Devyser Diagnostics AB compared to its main competitors.

Show all profitability ratios
for Devyser Diagnostics AB.

Provide ROE
for Devyser Diagnostics AB.

Provide ROA
for Devyser Diagnostics AB.

Provide ROIC
for Devyser Diagnostics AB.

Provide ROCE
for Devyser Diagnostics AB.

Provide Gross Margin
for Devyser Diagnostics AB.

Provide Operating Margin
for Devyser Diagnostics AB.

Provide Net Margin
for Devyser Diagnostics AB.

Provide FCF Margin
for Devyser Diagnostics AB.

Show all solvency ratios
for Devyser Diagnostics AB.

Provide D/E Ratio
for Devyser Diagnostics AB.

Provide D/A Ratio
for Devyser Diagnostics AB.

Provide Interest Coverage Ratio
for Devyser Diagnostics AB.

Provide Altman Z-Score Ratio
for Devyser Diagnostics AB.

Provide Quick Ratio
for Devyser Diagnostics AB.

Provide Current Ratio
for Devyser Diagnostics AB.

Provide Cash Ratio
for Devyser Diagnostics AB.

What is the historical Revenue growth
over the last 5 years for Devyser Diagnostics AB?

What is the historical Net Income growth
over the last 5 years for Devyser Diagnostics AB?

What is the current Free Cash Flow
of Devyser Diagnostics AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for Devyser Diagnostics AB.

DVYSR

Cash Flow Statement

Net Issuance of Common Stock

Devyser Diagnostics AB
Net Issuance of Common Stock

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Devyser Diagnostics AB
Net Issuance of Common Stock Peer Comparison

Comparables:

BIOG B

BONEX

VITR

SOBI

BIOA B

Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors

Company		Net Issuance of Common Stock	CAGR 3Y	CAGR 5Y	CAGR 10Y
D	Devyser Diagnostics AB STO:DVYSR	Net Issuance of Common Stock kr5.6m	CAGR 3-Years 5%	CAGR 5-Years 105%	CAGR 10-Years N/A
	Biogaia AB STO:BIOG B	Net Issuance of Common Stock -kr417k	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Bonesupport Holding AB STO:BONEX	Net Issuance of Common Stock kr990k	CAGR 3-Years -47%	CAGR 5-Years 60%	CAGR 10-Years N/A
	Vitrolife AB STO:VITR	Net Issuance of Common Stock N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Swedish Orphan Biovitrum AB (publ) STO:SOBI	Net Issuance of Common Stock kr476m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years 53%
	BioArctic AB STO:BIOA B	Net Issuance of Common Stock kr15m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A

What is Devyser Diagnostics AB's Net Issuance of Common Stock?

Net Issuance of Common Stock
5.6m SEK

Based on the financial report for Dec 31, 2023, Devyser Diagnostics AB's Net Issuance of Common Stock amounts to 5.6m SEK.

What is Devyser Diagnostics AB's Net Issuance of Common Stock growth rate?

Net Issuance of Common Stock CAGR 5Y
105%

Over the last year, the Net Issuance of Common Stock growth was -90%. The average annual Net Issuance of Common Stock growth rates for Devyser Diagnostics AB have been 5% over the past three years , 105% over the past five years .

Devyser Diagnostics AB
STO:DVYSR

Devyser Diagnostics AB
Net Issuance of Common Stock

Devyser Diagnostics AB
Net Issuance of Common Stock Peer Comparison

Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors

See Also

What is Devyser Diagnostics AB's Net Issuance of Common Stock?

Net Issuance of Common Stock
5.6m SEK

What is Devyser Diagnostics AB's Net Issuance of Common Stock growth rate?

Net Issuance of Common Stock CAGR 5Y
105%

Company

Help

Tools

Stocks

Devyser Diagnostics AB STO:DVYSR

Devyser Diagnostics AB Net Issuance of Common Stock

Devyser Diagnostics AB Net Issuance of Common Stock Peer Comparison

Competitive Net Issuance of Common Stock Analysis Latest Figures & CAGR of Competitors

See Also

What is Devyser Diagnostics AB's Net Issuance of Common Stock? Net Issuance of Common Stock 5.6m SEK

What is Devyser Diagnostics AB's Net Issuance of Common Stock growth rate? Net Issuance of Common Stock CAGR 5Y 105%

Company

Help

Tools

Stocks

Devyser Diagnostics AB
STO:DVYSR

Devyser Diagnostics AB
Net Issuance of Common Stock

Devyser Diagnostics AB
Net Issuance of Common Stock Peer Comparison

Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors

What is Devyser Diagnostics AB's Net Issuance of Common Stock?

Net Issuance of Common Stock
5.6m SEK

What is Devyser Diagnostics AB's Net Issuance of Common Stock growth rate?

Net Issuance of Common Stock CAGR 5Y
105%